Infectious Disease and Microbiology – Saccharomyces cerevisiae

Overview

Saccharomyces cerevisiae is a rapidly growing yeast with a worldwide distribution. It is best known as baker’s and brewer’s yeast because of its extensive use in baking, brewing, fermentation, and biotechnology.

Historically, S. cerevisiae was considered essentially nonpathogenic. However, it is now recognized as an uncommon opportunistic pathogen, particularly in immunocompromised or critically ill patients and in individuals with central venous catheters. Important infections include fungemia, peritoneal dialysis-associated peritonitis, septic arthritis, respiratory infection, and vaginitis.

Classification

Genus: Saccharomyces

Species: Saccharomyces cerevisiae

Microbiologic Characteristics

S. cerevisiae is:

• A yeast

• Rapid growing

• Usually composed of oval or round budding cells

• Capable of forming pseudohyphal structures under certain conditions

• A facultative organism capable of fermentation

Its ability to ferment carbohydrates explains its widespread use in:

Bread + beer + wine + other fermented products

High-Yield Microbiology Pattern

Rapid-growing budding yeast

• ●

Baker’s/brewer’s yeast

• ●

Usually nonpathogenic

• ●

Opportunistic fungemia in susceptible patients

→ Think Saccharomyces cerevisiae

Epidemiology

S. cerevisiae has a:

Worldwide distribution

It is commonly encountered in:

• Food

• Fermented beverages

• Baking products

• Environmental sources

• Human gastrointestinal and mucosal environments

Because exposure is extremely common while invasive disease is rare, infection usually requires significant:

Host or healthcare-related risk factors

Incubation Period

The incubation period is:

Unknown

Invasive disease usually represents opportunistic infection rather than an acute infection following a predictable exposure.

Opportunistic Pathogenicity

Historically, S. cerevisiae was considered:

Nonpathogenic

However, invasive infections are now well documented.

Disease occurs particularly in patients with:

• Significant immunosuppression

• Malignancy

• Critical illness

• Prolonged hospitalization

• Central venous catheters

• Broad-spectrum antimicrobial exposure

• Disruption of gastrointestinal mucosal barriers

Central Venous Catheter Association

One of the most important manifestations is:

FUNGEMIA

particularly in patients with:

Central venous catheters

Foreign intravascular material can provide a surface for adherence and persistent bloodstream infection.

High-Yield Clinical Pattern

Immunocompromised or critically ill patient

• ●

Central venous catheter

• ●

Blood cultures growing yeast

• ●

Saccharomyces cerevisiae

→ Saccharomyces fungemia

Fungemia

S. cerevisiae can cause true:

Bloodstream infection

Although uncommon, its isolation from blood should not automatically be dismissed as contamination, particularly when:

• Multiple blood cultures are positive

• Fever or sepsis is present

• A central venous catheter is present

• The patient is immunocompromised

• No more likely pathogen explains the illness

Probiotic-Associated Infection

An important clinical association involves probiotic preparations containing:

Saccharomyces boulardii

which is closely related to S. cerevisiae.

Rare cases of:

Saccharomyces fungemia

have occurred in susceptible hospitalized patients receiving or exposed to these yeast-containing probiotic products.

This association is particularly relevant in patients who are:

Critically ill, immunocompromised, or carrying central venous catheters.

High-Yield Probiotic Pattern

Critically ill patient

• ●

Central venous catheter

• ●

Saccharomyces-containing probiotic exposure

• ●

Fungemia

→ Consider invasive Saccharomyces infection

Peritoneal Dialysis-Associated Peritonitis

S. cerevisiae may cause:

Peritonitis

in patients undergoing:

Chronic ambulatory peritoneal dialysis

The peritoneal dialysis catheter can provide:

Portal of entry + foreign surface for persistent infection

High-Yield Dialysis Pattern

Peritoneal dialysis

• ●

Peritonitis

• ●

Yeast isolated from peritoneal fluid

→ Consider Saccharomyces cerevisiae among fungal causes

Septic Arthritis

S. cerevisiae has occasionally been associated with:

Septic arthritis

This represents an uncommon invasive manifestation and requires careful evaluation because recovery of an unusual yeast from a normally sterile joint specimen may represent:

True invasive fungal infection

Respiratory Tract Infection

S. cerevisiae may be recovered from respiratory specimens.

True respiratory infection is uncommon and is most relevant in:

Immunocompromised patients

Because yeast can colonize mucosal surfaces, isolation from respiratory secretions alone does not necessarily establish invasive disease.

Clinical findings, imaging, host factors, and—in selected cases—histopathologic evidence should be considered.

Vaginitis

S. cerevisiae can occasionally cause:

Vaginitis

although:

Candida species

are much more common causes of vulvovaginal yeast infection.

Symptoms may resemble candidal vulvovaginitis, including:

• Vulvar pruritus

• Irritation

• Burning

• Vaginal discharge

Diagnosis

The primary diagnostic method is:

CULTURE

The organism may be recovered from:

• Blood

• Peritoneal fluid

• Synovial fluid

• Respiratory specimens

• Vaginal specimens

• Other appropriate clinical material

Blood Culture Interpretation

Recovery of S. cerevisiae from:

Blood

should receive particular attention.

In a patient with:

Fever + central venous catheter + immunocompromise

the isolate should be evaluated as a potential:

True bloodstream pathogen

rather than automatically classified as a contaminant.

Culture

Culture demonstrates:

Rapidly growing yeast

Laboratory identification is important because Saccharomyces may initially be confused with other clinically relevant yeasts.

Saccharomyces vs. Candida

Both are:

Budding yeasts

and both may be associated with invasive bloodstream infection.

However:

Saccharomyces cerevisiae

→ Baker’s/brewer’s yeast

→ Usually low pathogenicity

→ Invasive infection uncommon

→ May be associated with central venous catheters and probiotic exposure

Candida

→ Much more common human opportunistic yeast

→ Major cause of candidemia

→ Frequently causes mucosal and invasive infections

Saccharomyces vs. Rhodotorula

Saccharomyces

→ Rapid-growing budding yeast

→ Baker’s/brewer’s yeast

→ Opportunistic fungemia

Rhodotorula

→ Characteristic pink, coral, orange, or red pigmentation

→ Strong central-line fungemia association

→ Often initially considered a contaminant

Both can become important opportunistic pathogens in patients with:

Indwelling intravascular devices

Treatment of Systemic Infection

The source recommends:

Intravenous amphotericin B

for:

Systemic infections

Because invasive Saccharomyces disease is uncommon, treatment should be individualized according to:

Disease severity + infection site + susceptibility + host factors

Source Control

For catheter-associated fungemia, an important management principle is:

Evaluate the central venous catheter as the infectious source

Removal of an implicated catheter may be important when clinically appropriate.

Thus:

Antifungal therapy + source control

are key principles in invasive disease.

High-Yield Fungemia Management

Saccharomyces fungemia

→ Active systemic antifungal therapy

• ●

Evaluate/remove implicated central venous catheter when appropriate

• ●

Stop avoidable Saccharomyces-containing probiotic exposure

• ●

Assess for complications of persistent fungemia

Treatment of Vaginitis

For S. cerevisiae-associated vaginitis, the source lists:

Topical azole therapy

Because Candida is a much more common cause of vulvovaginal yeast infection, culture and species identification may become particularly useful in:

Persistent or recurrent atypical cases

Prevention

There is no vaccine against S. cerevisiae infection.

Prevention of healthcare-associated invasive disease centers on:

• Appropriate central-line care

• Removal of unnecessary intravascular devices

• Good hand hygiene

• Appropriate management of immunocompromised patients

• Careful consideration of live yeast-containing probiotics in highly susceptible hospitalized patients

High-Yield Clinical Pattern

Immunocompromised/critically ill patient

• ●

Central venous catheter

• ●

Fungemia

• ●

Rapid-growing baker’s/brewer’s yeast

→ Think SACCHAROMYCES CEREVISIAE

Exam Essentials

Genus: Saccharomyces

Species: S. cerevisiae

Organism: Yeast

Growth: Rapid

Common name: Baker’s/brewer’s yeast

Distribution: Worldwide

Traditional view: Generally nonpathogenic

Modern significance: Rare opportunistic pathogen

Major susceptible hosts: Immunocompromised and critically ill patients

Major device association: Central venous catheter

Major invasive infection: Fungemia

Other infections: Peritoneal dialysis-associated peritonitis, septic arthritis, respiratory infection, and vaginitis

Important additional association: Exposure to Saccharomyces boulardii-containing probiotics in susceptible hospitalized patients

Diagnosis: Culture

Source treatment for systemic infection: IV amphotericin B

Source treatment for vaginitis: Topical azole

Management principle: Systemic antifungal treatment plus source control when an infected catheter or other device is implicated

Key clinical pearl: Saccharomyces cerevisiae is the familiar baker’s and brewer’s yeast and is ordinarily of low pathogenicity, but it can become a true opportunistic pathogen. The classic invasive setting is fungemia in an immunocompromised or critically ill patient with a central venous catheter; yeast-containing probiotic exposure is another important clue. In this setting, the organism should not automatically be dismissed as a contaminant, and systemic antifungal therapy together with appropriate source control should be considered.